Webinar – Cognitive Neuroscience comes of Age: Using Closed-loop Neuromodulation to induce clinical change
During the past several decades we’ve witness tremendous advances in our ability to study human brain function. Now, for example, we can probe processing differences at the level of the cortical laminar, and identify the brain’s intrinsic network architecture via recording slowly fluctuating, spontaneous neural activity at rest. Yet, despite these and other advances, we […]
Webinar – Measurement and Structure of Cognition across the world: Cultural and language considerations
During this intermediate level session Dr. Gross will review the process of data harmonization involving cognitive tests, the role of neuropsychological expertise to inform statistical methods, and cultural issues in cognitive testing pertinent for aging research
Webinar – Changes in cognition during the preclinical phase of Alzheimer’s Disease: Findings from the Wisconsin Registry for Alzheimer’s Prevention (WRAP)
The cognitively unimpaired stage of Alzheimer’s disease (AD) is quite long in duration, but the interval varies widely from person to person. This talk will describe some of the brain and cognitive changes that we have observed from over a decade of biomarker imaging within the Wisconsin Registry for Alzheimer’s Prevention (WRAP) and related studies. […]
Webinar – Financial Decision Making and Fraud in Older Age: Neuropsychology, Neuroimaging, and Policy Considerations
Financial exploitation of older adults is a significant public health concern. However, the reasons why certain older adults are susceptible to scam and fraud are poorly understood. This presentation will review neuropsychological, neuroimaging, and other scientific evidence focused on elucidating the underlying factors and neurobiological mechanisms associated with risk of financial exploitation in older age. […]
Webinar – Frontotemporal dementia: Assessment, management and considerations for culturally diverse and low resource settings
Frontotemporal dementia is a relatively rare dementia syndrome characterised by insidious and progressive changes in behaviour and personality. Currently, no disease-modifying treatment or cure exists, and differential diagnosis is challenging. In this webinar we will provide an overview of current clinical recommendations for the diagnosis of behavioural-variant frontotemporal dementia, with a focus on differentiation from […]
Webinar – Acute TBI Rehabilitation: Treatment Approaches Associated with Better Outcomes
Comparative effectiveness research is identifying treatment approaches delivered during acute inpatient TBI rehabilitation associated with better outcomes at hospital discharge and across the first year following injury. This webinar will present evidence for treatment associated with better outcomes following TBI and the collaborative role neuropsychologists can play in assisting interdisciplinary rehabilitation teams to implement these […]
Webinar – The Neuropsychology of Creativity
In the 70 years since Guilford used his presidential address at the APA to launch the scientific investigation of creativity, we have learned a great deal about how to define creative achievements, identify creative individuals, and examine the associated psychological and physiological processes. This presentation summarizes work conducted at the Tennenbaum Center for the Biology […]
Webinar – Research and Clinical Practice: Sex Differences in Dementia
Sex and gender differences have become increasingly recognized across the dementias in recent years. In this webinar, Dr. Rachel Buckley will review current evidence for sex differences in Alzheimer’s disease risk across the measurement spectrum – from epidemiological evidence to clinical phenotypes and biological markers. Further, she will discuss the question of whether these sex […]
Webinar – An Introduction to Neurodegenerative Pathology for Neuropsychologists
Autopsy remains the gold standard for diagnosis of neurodegenerative disease. Neurodegeneration is defined as the progressive loss of selectively vulnerable neurons in specific anatomic networks, thus leading to neuronal death and cognitive impairment. Neurodegenerative diseases are therefore characterized by the clinical phenotype (e.g. a dementia syndrome), anatomic patterns of atrophy or vulnerability, and pathology at […]
Webinar – Cannabis and Neuropsychological Functioning: An Update on Adverse Effects in Adolescence and Beyond
Public sentiment and laws around the use of cannabis continue to become more permissive in the United States alongside a growing perception of effective medicinal applications. Yet, there is a robust literature documenting cannabis-associated worsening of neuropsychological functioning. What does the current scientific research suggest about the type and magnitude of neuropsychological side-effects from recreational […]